FDA warns Philips of software malfunction in Lumify ultrasound system linked to deaths and injuries
On October 9, 2026 the FDA’s Center for Devices and Radiological Health issued a warning about a software defect in Philips’ Lumify Diagnostic Ultrasound System. The defect has impaired scanning, leading to delayed diagnoses and has been linked to four patient deaths and eight severe injuries as of September 29. Philips told health‑care providers to ensure stable Wi‑Fi or cellular connections while it develops a software fix and investigates the root cause.
Why it matters
The company’s statement that a fix is being developed signals ongoing remediation, but the warning could generate recall costs, liability exposure and pressure on sales of the Lumify device. Investors should monitor any impact on Philips’ earnings and dividend sustainability.
Key facts
- 1The FDA issued a warning on October 9, 2026 about a software malfunction in Philips’ Lumify Diagnostic Ultrasound System. gurufocus.com
- 2The malfunction has been linked to four reported fatalities and eight severe injuries as of September 29. gurufocus.com
- 3Philips advised health‑care providers to maintain reliable Wi‑Fi or cellular connectivity while a software update is developed. gurufocus.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.